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Abstract
Rhodostomin (Rho) is an RGD protein that specifically inhibits integrins. We found that Rho mutants with the P48A mutation
4.4–11.5 times more actively inhibited integrin a5b1. Structural analysis showed that they have a similar 3D conformation
for the RGD loop. Docking analysis also showed no difference between their interactions with integrin a5b1. However, the
backbone dynamics of RGD residues were different. The values of the R2 relaxation parameter for Rho residues R49 and D51
were 39% and 54% higher than those of the P48A mutant, which caused differences in S
2,R ex, and te. The S
2 values of the
P48A mutant residues R49, G50, and D51 were 29%, 14%, and 28% lower than those of Rho. The Rex values of Rho residues
R49 and D51 were 0.91 s
21 and 1.42 s
21; however, no Rex was found for those of the P48A mutant. The te values of Rho
residues R49 and D51 were 9.5 and 5.1 times lower than those of P48A mutant. Mutational study showed that integrin a5b1
prefers its ligands to contain (G/A)RGD but not PRGD sequences for binding. These results demonstrate that the N-terminal
proline residue adjacent to the RGD motif affect its function and dynamics, which suggests that the dynamic properties of
the RGD motif may be important in Rho’s interaction with integrin a5b1.
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Introduction
The tripeptide sequence Arg-Gly-Asp (RGD) is the consensus
sequence of many adhesive proteins, such as fibronectin, fibrinogen,
vitronectin, and von Willebrand factor [1,2,3]. In mammals, 18 a
and 8 b subunits assemble into 24 integrins. The RGD sequence is
recognized by half of the 24 known integrins, whereas alternative
short peptide sequences are recognized by other integrins [4]. In
addition to adhesive proteins, the RGD sequence is found in many
proteins, including dendroaspin [5], decorsin [6], savignygrin [7],
streptopain [8], c-bungarotoxin [9], human herpesvirus 8 envelope
glycoprotein B [10], and disintegrins [11]. Disintegrins are the
peptides found in snake venoms of the viper family and mainly
inhibit the functions of b1- and b3-associated integrins. They were
first identified as inhibitors of integrin aIIbb3 and were subse-
quently shown to bind with high affinity to other integrins and to
block the interaction of integrins with RGD-containing proteins.
They contain 47–84 amino acids with 4–7 disulfide bonds. The
RGD or KGD sequences in this disintegrin family are the most
important in recognizing the integrin aIIbb3 [12,13,14,15,16].
Analyses of 3D disintegrin structures show that they consist of a
series of tightly packed loops and turns held together by disulfide
bonds [17,18,19,20,21]. The RGD motif is located at the apex of a
5–11 residue loop, between two b strands of the protein, protruding
10–17 A ˚ from the protein core [13]. The R and D sidechains in a
flexible loop do not interact but nearly oppose each other by 180u.
Many studies have shown that the residues flanking the RGD
motif of RGD-containing proteins affect their binding specificities
and affinities on integrins [7,10,22,23,24,25]. For example, disin-
tegrins with an ARGDW sequence have a higher affinity for binding
with the integrin aIIbb3, whereas disintegrins with an ARGDN
sequencepreferentially bind with integrinsavb3a n da5b1 [24].The
amino acid sequences of the RGD loop from RIPRGDMP to
TAVRGDGPofrhodostomin(Rho),resulting ina 196-fold decrease
in inhibiting integrin aIIbb3 [9]. Replacement of the N-terminal
alanine with the proline of the RGD motif of elagantin, a disintegrin
with an ARGDMPsequence, diminishes its binding to integrin a5b1
[25], which suggests that replacing the N-terminal proline with the
alanine of the RGD motif may increase its binding to integrin a5b1.
Therefore,itisofinteresttostudytheeffectof theN-terminalproline
or alanine residue adjacent to the RGD motif on the function,
structure, and dynamic relationships of disintegrin.
In this study, we used Rho as the model protein to investigate
the effect of the N-terminal proline residue adjacent to the RGD
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relationships of RGD-containing proteins. Rho is obtained from
Calloselasma rhodostoma venom and belongs to the family of
disintegrins [26,27,28]. It consists of 68 amino acids, including
12 residues of cysteine and a PRGDMP sequence at positions 48–
53. We previously showed that Rho expressed in Pichia pastoris (P.
pastoris) has the same function and structure as native protein [28].
In the present study, we expressed Rho P48A mutants and
determined their activities in inhibiting the integrins aIIbb3, avb3,
and a5b1. We also used nuclear magnetic resonance (NMR)
spectroscopy to compare 3D structures and backbone dynamics.
Materials and Methods
Expression of Rho and its Mutants in P. pastoris and
Purification
The expression of Rho and eleven mutants (P48A, M52W,
P48A/M52W, M52N, P48A/M52N, M52G/P53W, P48A/
M52G/P53W, M52D/P53L, P48A/M52D/P53L, M52D/
P53M, and P48A/M52D/P53M) in P. pastoris was accomplished
by following protocols previously described [27,28]. The expres-
sion kit and the yeast transfer vector, pPICZaA, were purchased
from Invitrogen. The wild-type construct was used to produce the
mutations using overlap extension PCR. The construct was
transformed into the Pichia strain, X33, using a Pichia EasyComp
kit from Invitrogen.
Unlabelled and
15N-labelled Rho and its mutants were
produced by following protocols previously described [27,28].
The unlabelled proteins were produced as follows: 100 mL of cell
stock grew at 30uC in 100 mL of yeast nitrogen base (YNB)
medium (1% yeast extract, 2% peptone, and 2% dextrose)
containing 100 mg/mL of Zeocin for 48 h. Cells were then
transferred into 900 mL of YNB medium. After another 48 h, the
cells were collected by centrifugation and grown in 1 L of minimal
methanol medium (1.34% YNB with ammonium sulphate without
amino acids and 4610
25% biotin). Methanol (1% w/v) was added
once every 12 h to induce protein expression for 2 days. The
15N-
labelled proteins were produced as follows: 100 mL of cell stock
grew at 30uC in 100 mL of
15N minimal medium (0.34% YNB
without ammonium sulphate and amino acids, 2% dextrose, and
0.05%
15NH4Cl) in 100 mM of potassium phosphate buffer with
100 mg/mL of Zeocin for 48 h. The cells were then transferred
into 900 mL of
15N minimal medium. After another 24 h, the cells
were collected by centrifugation and grown in 1 L of
15N minimal
medium in 100 mM of potassium phosphate buffer with
4610
25% biotin. The methanol in the medium was maintained
at 1% (w/v) in order to induce protein expression for 48 h.
The supernatant was collected by centrifugation and dialyzed
twice against 10 L of H2O and once against 5 L of binding buffer
(50 mM Tris-HCl buffer at pH 8.0). The dialyzed solution was
loaded into a Ni
2+-chelating column and proteins were eluted
using elution buffer containing 200 mM of imidazole. Proteins
were then purified using C18 reversed-phase HPLC with a
gradient of 20–30% acetonitrile. The recombinant proteins were
more than 95% pure, as determined using tricine-SDS-PAGE.
Fibronectin Purification
Fibronectin was purified from citrated human plasma using
gelatin-Sepharose 4B affinity chromatography as previously
described [29]. One hundred millilitres of human plasma was
centrifuged at 5000 rpm for 30 min and then filtered through
Whatman filter paper. The filtrate was applied to a pre-
equilibrated gelatin-Sepharose resin with phosphate-buffered
saline (PBS: 10 mM phosphate buffer, 0.15 M NaCl [pH 7.4])
at pH 7 containing 5 mM EDTA, 0.05% (w/v) NaN3, and 1 mM
benzamidine. The resin was washed with 1 M NaCl and 1 mM
benzamidine at pH 7, and fibronectin then was eluted using 1 M
urea and 1 mM benzamidine at pH 7. The fractions were dialyzed
three times against 4 L of PBS buffer at pH 7.4 and concentrated
using Amicon with a 10-kDa cutoff membrane. The yields of
fibronectin were 15–20 mg, and the purification of human
fibronectin was greater than 95% as determined using SDS-
PAGE. Purified fibronectin was stored at 270uC until it was used.
Mass Spectrometric Measurements
The molecular weights of Rho mutant proteins were confirmed
using an API 365 triple quadrupole mass spectrometer equipped
with a TurboIonSpray source (PE-Sciex, Thornill, Canada).
Protein solutions (1–10 mM in 50–90% methanol or acetonitrile
with 0.1% formic acid) were infused into the mass spectrometer
using a syringe pump (Harvard Apparatus, South Natick, MA,
USA) at a flow rate of 12–20 mL/min to acquire full-scan mass
spectra. The electrospray voltage at the spraying needle was
optimized at 5000–5300 V. The molecular weights of proteins
were calculated using computer software provided with the API
365 mass spectrometer.
Platelet Aggregation Assay
Venous blood (9 parts) from healthy donors who had not
received any medication for at least two weeks were collected in
3.8% sodium citrate (1 part). Blood was centrifuged at 706g for
10 min to obtain platelet-rich plasma (PRP) and allowed to stand
for 5 min. Then, PRP was collected. Platelet-poor plasma (PPP)
was prepared from the remaining blood by centrifuging it at 8006
g for 10 min. The PPP platelet count was measured on a
haematology analyzer, and the platelets were diluted to 250,000
platelets/mL. A solution of PRP (190 mL) and either Rho or PBS
buffer (10 mL) was incubated for 5 min in a Hema Tracer 601
aggregometer at 37uC. Ten microlitres of 200 mM ADP was
added to monitor the response of platelet aggregation by light
transmission.
Cell Adhesion Assay
A cell adhesion assay was done using protocols previously
described [29]. Ninety-six-well microtitre plates (Costar, Corning,
USA) were coated with 100 mL of PBS buffer containing 200 mg/
ml fibrinogen or 25 mg/mL fibronectin, and incubated overnight
at 4uC. Non-specific protein binding sites were blocked by
incubating each well with 200 mL of heat-denatured 1% bovine
serum albumin (BSA) (Calbiochem) at room temperature for
1.5 h. The heat-denatured BSA was discarded and each well was
washed twice with 200 mL of PBS.
Chinese hamster ovary (CHO) cells that expressed the integrins
avb3 (CHO-avb3) and aIIbb3 (CHO-aIIbb3) were kindly
provided by Dr. Y. Takada (Scripps Research Institute) and
maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)
medium [29]. Human erythroleukemia K562 cells were purchased
from ATCC and cultured in Roswell Park Memorial Institute
(RPMI)-1640 medium containing 5% foetal calf serum. Harvested
K562 cells were washed in PBS buffer containing 1 mM EDTA
and resuspended in Tyrode’s buffer (150 mM NaCl, 5 mM KCl,
and 10 mM Hepes) at pH 7.35 containing 1 mM MgSO4,2m M
CaCl2, and 500 mM MnCl2. CHO and human erythroleukemia
K562 cells were diluted to 3 and 2.5610
5 cells/mL, respectively,
and 100 mL of the cells were used for the assay. Rho and its
mutants (0.001–500 mM), which were used as inhibitors, were
added to the cells and incubated at 37uC in a 5% CO2 atmosphere
for 15 min. The treated cells were then added to the coated plate
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then discarded and non-adhered cells were removed by washing
them twice with 200 mL of PBS. After the non-adhered cells had
been removed by rinsing the wells with the same buffer, adhered
cells were quantified using a crystal violet assay. The well was fixed
with 100 mL of 10% formalin for 10 min and then dried. A
solution of 50 mL of 0.05% crystal violet was added to the well at
room temperature for 20 min. Each well was then washed four
times with 200 mL of distilled water and dried. Colorization was
done by adding 150 mL of colorizing solution (50% alcohol and
0.1% acetic acid). The resulting absorbance was read at 600 nm
and the readings were correlated with the number of adhering
cells. Inhibition was defined as
% inhibition~100{
OD600 Rho protein{treated sample ðÞ
OD600 untreated sample ðÞ
  
|100
The reported IC50 values are the average of at least three separate
experiments.
Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR experiments were done at 27uC on a Bruker Avance 600-
and 700-MHz spectrometer equipped with pulse field gradients
and xyz-gradient triple-resonance probes. In these experiments,
samples were dissolved in 10% D2O/90% H2O or 100% D2Oa ta
concentration of 3 mM; pH was adjusted with 100 mM KOD to
6.0. The data were processed with Topspin Version 1.3 software
and analyzed with Aurelia software. 2D NOESY, TOCSY, and
DQF-COSY NMR spectra were recorded in the phase-sensitive
absorption mode with quadrature detection in both F1 and F2
dimensions. A concentration of 2 mM
15N labeled Rho and its
P48A mutant was used for the 2D
1H-
15N HSQC, 3D
1H-
15N
edited-TOCSY-, and NOESY-HSQC experiments. Mixing times
of 30–90 ms and 60–150 ms were used for TOCSY and NOESY
experiments, respectively. The centre frequencies of double
resonance experiments were 4.75 ppm (
1H) and 118 ppm (
15N).
The observed
1H chemical shifts were referenced with respect to
the H2O or HOD signal, which was 4.754 ppm downfield from
external sodium 3-trimethylsilylpropionate-2,2,3,3-d4 (TSP) in
D2O (0.0 ppm) at 300uK. The nitrogen chemical shift was
referenced to external
15NH4Cl (3 mM in 1 M HCl) at 300uK,
which is 24.93 ppm downfield from liquid NH3.
Structure Calculations
Structures were calculated using the program X-PLOR with the
hybrid distance geometry-dynamical simulated annealing method
[30]. NOESY cross-peak intensities—categorized into strong,
medium, weak, and very weak—were converted into distance
constraints of 1.8–2.8, 1.8–3.6, 1.8–5.0, and 2.5–6.0 A ˚, respec-
tively. Pseudoatom corrections were used for methylene, methyl,
and aromatic protons, and an additional 0.5 A ˚ was added to the
upper limit distances involving methyl protons. The dihedral
angles Q were determined from the
3JNHa coupling constants. For
3JNHa values less than 5 Hz, Q values were restricted from 230u to
290u, and for
3JNHa values greater than 10 Hz, Q values were
restricted from 2100u to 2170u. Two restraints were used for
each NH-CO backbone hydrogen bond with dN-O restricted to
2.4–3.3 A ˚ and d H-O to 1.7–2.3 A ˚. A family of 100 structures was
generated using NOE distance, dihedral angle, and hydrogen
bond restraints. The S-S covalent bonds were deleted and
reintroduced as pseudo-NOE distances with the S-S distances
constrained to the upper limit of 2.1 A ˚. During the first phase of
dynamics at 2000uK, the value of the force constant of the NOE
term was kept constant at 50 kcal/mol
21 A ˚ 22. The repulsion term
was gradually increased from 0.03 to 4.0 kcal/mol
21 A ˚ 22, and the
torsion angle term from 5 to 200 kcal/mol
21rad
22. The simulated
annealing refinement consisted of a 9-ps cooling dynamic followed
by 200 cycles of Powell minimization. The twenty lowest-energy
structures were accepted based on violations of distance restraints
less than 0.5 A ˚, dihedral angle restraints less than 5u, a van der
Waals energy cutoff value of 35 kcal/mol, and an NOE energy
cutoff value of 55 kcal/mol. The structure figures were prepared
using the MOLMOL or the PyMOL program [31,32].
Measurements of NMR Dynamics
Backbone dynamics of Rho and its P48A mutant were studied
by two-dimensional proton-detected heteronuclear NMR spec-
troscopy. The
15N- spin-lattice (R1) and spin-spin (R2) relaxation
rate constants and steady-state
1H-
15N NOEs were measured from
1H-detected
1H-
15N correlation spectra recorded with sensitivity-
enhanced pulse sequences. A recycle delay of 6 s was used, and
128 complex T1 increments of 32 scans were acquired. A series of
10 experiments with relaxation delays of 30, 100, 150, 300, 450,
600, 800, 1000, 1500, and 3000 ms were done to measure T1.A
series of 10 experiments with relaxation delays of 18, 36, 48, 72,
90, 100, 120, 150, 300 and 500 ms were done to measure T2. The
longitudinal and transverse relaxation rate constants, R1 and R2,
were obtained from exponential fits of the peak height data using
least-squares fit software SigmaPlot (Jandel Scientific). The
reported Ri values are the mean values of two independent data
sets. In the NOE experiment, two spectra—one with the NOE and
one without—were collected. The NOE was calculated as the ratio
of peak heights in spectra collected with and without NOE. The
reported NOE value was the average value of three pairs of NOE
experiments.
The heteronuclear
15N relaxation rate constants, R1 and R2, and
the
1H-
15N steady state NOE values were analyzed using the
FastModelFree program [33]. In this approach, the overall and
internal molecular motions were assumed to be independent, and
the spectral density function for a molecule undergoing isotropic
tumbling was calculated using the appropriate expression:
J(v)~
2
5
S2tm
1z vtm ðÞ
2 z
S2
f {S2t
1z vt ðÞ
2
"#
,
Table 1. Summary of inhibition of platelet aggregation and
cell adhesion by Rho and its P48A mutant.
IC50 (nM)
a
Integrin/Cell Rho P48A Mutant IC50Rho/IC50P48A
aIIbb3/Platelet
b 83.2610.4 110.3614.1 0.75
aIIbb3/CHO
c 21.0611.2 31.667.2 0.66
avb3/CHO
d 13.065.7 15.863.3 0.82
a5b1/K562
e 256.8627.5 59.0618.4 4.35
aThe IC50 values are the average value of 3–5 experiments.
bInhibition of ADP-induced platelet aggregation by Rho proteins was measured
in human PRP.
cInhibition of integrin aIIbb3-expressing CHO cell adhesion to immobilized
fibrinogen by Rho proteins.
dInhibition of integrin avb3-expressing CHO cell adhesion to immobilized
fibronectin by Rho proteins.
eInhibition of K562 cell adhesion to immobilized fibronectin by Rho proteins.
doi:10.1371/journal.pone.0028833.t001
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t~ 1
tm z 1
te and S2~S2
f S2
s, tm is the overall rotational
correlation time of the molecule, te is the effective correlation time
for the motions on the slower of the two time scale, S
2 is the square
of the generalized order parameter, and S
2
s and S
2
f are the squares
of order parameters for the motion on the slow and fast time scale,
respectively [34].
Molecular Docking
The dockings of Rho and its P48A mutant to integrin a5b1
were done using the docking program HADDOCK 2.1 with
hydrogen bond and distance restraints [35]. The structure of
integrin a5b1 was modelled using the program MODELLER [36]
with integrin avb3 (PDB code 1L5G) as the template, and the
starting structures of Rho and its P48A mutant were their average
minimized NMR structures. The interaction restraints were
derived from the X-ray structure of integrin avb3 in complex
with a cyclic pentapeptide (c(-RGDf[NMe]V-)) using the software
iMoltalk [37]. The defined distance threshold was 4 A ˚, and the
interaction restraints between the RGD motif and integrin were
used for calculation. The input restraints between the R49, G50,
and D51 residues and integrin a5b1 were 30, 7, and 39,
respectively. They were the contacts between the R49 residue
and the residues F187, Q189, and D227 of integrin a5, between
the G50 residue and the residues L214 and S216 of b1, and
between the D51 residue and the residues S121, Y122, S123,
G212, N213, and E218 and Mn
2+ of the MIDAS (metal-ion-
dependent adhesion site) of b1. Additional 0.5 A ˚ distance was
added to the upper and lower limits in the direct interaction
restraints. Using these restraints, the standard HADDOCK
protocol for protein docking was done with minor modifications.
This protocol combines three stages of molecular dynamics
calculations, including heating and cooling with a progressive
increase of the flexibility at the binding interface. In the first stage,
500 conformations were calculated using a rigid-body docking
protocol. The best 100 structures in terms of their inter-molecular
energies were refined by semi-flexible simulated annealing in the
second stage. Both the side-chains and the backbone atoms of the
residues 46–54 were defined as flexible and allowed the residues to
move in a semi-rigid-body docking protocol to search for
conformational rearrangements. The resulting 100 structures with
the lowest intermolecular energy values were refined with explicit
water molecules in the last stage. The structures were classified by
clustering based on the pairwise RMSD differences. The structures
were found by fitting them over the RGD residues with an average
RMSD value ,1.5 A ˚ for the backbone atoms of all the amino
acids in 100 integrin complexes.
Table 2. Summary of inhibition of K562 cell adhesion to fibronectin by Rho and its mutants.
P-type Protein
aP IC50 (nM) A-type Protein
bA IC50 (nM)
PIC50 (nM)/
AIC50 (nM)
P R G D M P 256.8687.5 A RG D M P 5 9 . 0 628.4 4.4
PR G D W P 403.5643.9 A RG D W P5 2 . 0 614.4 7.8
PR G D N P 357.0680.6 A RG D N P4 4 . 1 617.6 8.1
PR G D GW 1238.46632.9 A RG D GW 190.8675.9 6.5
PR G D DL 3017.06801.5 A RG D DL526.76200.3 5.7
PR G D DM 4047.361784.3 A RG D DM350.8681.0 11.5
aP-type proteins contain a P residue at the 48 position.
bA-type proteins contain a A residue at the 48 position.
The mutated positions are shown in boldface.
doi:10.1371/journal.pone.0028833.t002
Table 3. Summary of structural restraints and statistics for
Rho P48A mutant.
Restraints used in the structure calculation
Distance and dihedral angle restraints
Intra-residue 145
Sequential 111
Medium range 333
Long range 387
Hydrogen bonds 9
Dihedral angles 57
Total 1048
Energy statistics
X-PLOR energy (kcal mol
21)
ENOE 23.3866.91
Evdw 11.4962.99
Geometric statistics
Deviations from idealized geometry
All backbone atoms (A ˚) 1.0460.23
Backbone atoms (13–14, 20–21,
33–34, 37–38, 43–45, and 55–57) (A ˚)
0.3860.10
All heavy atoms (A ˚) 1.6260.25
Heavy atoms (13–14, 20–21,
33–34, 37–38, 43–45, and 55–57) (A ˚)
0.8760.12
Ramachandran analysis
Most favored regions (%) 75.2
Additionally allowed regions (%) 23.6
Generously allowed regions (%) 1.2
doi:10.1371/journal.pone.0028833.t003
Figure 1. Structures of Rho P48A mutant. Stereo views of the 20
lowest-energy NMR structures of the Rho P48A mutant.
doi:10.1371/journal.pone.0028833.g001
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The coordinates of 20 calculated structures of P48A mutant
were deposited in the Protein Data Bank under accession number
2PJI.
Ethics Statements
The ethics approval for our study was approved by an
independent ethics committee of National Cheng Kung Univer-
sity. The collection of human serum was followed the guidelines
and regulation. We have obtained written informed consent from
all participants involved in this study.
Results
Protein Expression and Purification of Rho and its
Mutants
Rho and eleven mutants were expressed with pPICZaA vector
in P. pastoris X33 strain. Rho and its P48A, M52W, P48A/M52W,
M52N, P48A/M52N, M52G/P53W, P48A/M52G/P53W,
M52D/P53L, P48A/M52D/P53L, M52D/P53M, and P48A/
M52D/P53M mutants produced in P. pastoris were purified to
homogeneity, according to SDS-polyacrylamide gel electrophore-
sis (data not shown), using Ni
2+-chelating chromatography and
C18 reversed-phase HPLC. The yields of Rho and its mutants
were 10–25 mg/L. Mass spectrometry showed that the experi-
mental molecular weights deviated less than 1 Da when compared
with the theoretical values, which had been calculated by assuming
that all cysteines form disulfide bonds, and would result in the
formation of six disulfide bonds in Rho and its mutants (Table S1
and Figure S1).
Inhibition of Platelet Aggregation
Rho produced in P. pastoris inhibited platelet aggregation with a
KI of 83.2610.4 nM (Table 1), which is as potent as native Rho
[21]. The mutation of P48 to A in Rho caused only a 1.3-fold
decrease in activity in the inhibition of platelet aggregation with a
KI of 110.3614.1 nM. These results showed that the P48 residue
in the RGD loop of Rho has little effect on the interaction between
Rho and platelet integrin aIIbb3.
Inhibition of Cell Adhesion to Fibrinogen and Fibronectin
The adhesion of CHO cells that express aIIbb3 and avb3t o
immobilized fibrinogen is dependent on the affinity states of the
aIIbb3 and avb3 integrins, respectively [38]. These assays used
mAbs that blocked the functions of aIIbb3 and avb3 [25,39]. In
addition, the adhesion of K562 cells to fibronectin in the presence
of 500 mMo fM n
2+ is predomiantly a5b1-dependent [25]. Rho
and its P48A mutant inhibited the adhesion of CHO cells that
express the integrin aIIbb3 to immobilized fibrinogen with the
IC50 values of 21611.2 and 31.667.2 nM, respectively (Table 1).
Figure 2. 2D
1H-
15N HSQC spectra of Rho (black) and its P48A mutant (red) at pH 6.0. Correlation peaks are labelled according to residue
type and sequence number. The peaks connected by lines correspond to Gln and Asn side chain NH2 groups. The peaks denoted by the suffix ‘‘s’’
(e.g., Q60s-, N11s-) are the side-chain resonances of Asn, Gln, and Arg.
doi:10.1371/journal.pone.0028833.g002
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induced platelet aggregation. Similarly, Rho and its P48A mutant
inhibited the adhesion of CHO cells that express the integrin avb3
to immobilized fibrinogen with the IC50 values of 1365.7 and
15.863.3 nM, respectively. Rho and its P48A mutant inhibited
K562-cell adhesion to immobilized fibronectin with the IC50
values of 256.8687.5 and 59.0628.4 nM, respectively. In contrast
to their inhibition of integrins aIIbb3 and avb3, P48A mutant
showed a 4.4-fold increase in its inhibition of integrin a5b1. These
results showed that the N-terminal alanine residue adjacent to the
RGD motif increased its inhibition of integrin a5b1, but not of
integrins aIIbb3 and avb3.
We also expressed a series of Rho proteins, M52W, P48A/
M52W, M52N, P48A/M52N, M52G/P53W, P48A/M52G/
P53W, M52D/P53L, P48A/M52D/P53L, M52D/P53M, and
P48A/M52D/P53M mutants to confirm the effect of the N-
terminal alanine of the RGD motif on inhibiting integrin a5b1.
The results were consistent with that of P48A mutant, and the
mutant proteins containing a P48A mutation showed a 4.4–11.5-
fold increase in the inhibition of integrin a5b1 (Table 2). These
results suggest that RGD proteins with the RGD motif containing
an N-terminal proline residue may weaken their binding to
integrin a5b1.
Structure Determination
The solution structure of Rho and the 3D structure of the P48A
mutant were determined using NMR spectroscopy and the hybrid
distance geometry-dynamical simulated annealing method [27].
NMR spectra were recorded at pH 6.0. NMR assignment of the
P48A mutant was obtained by analyzing standard 2D homonu-
clear and 3D heteronuclear NMR data (data not shown). We also
did NOESY experiments at pH 6.0 in 100% D2O to determine
their six disulfide bonds. Their pairings were identified using CbH
to CbH, CaHt oC bH, and CaHt oC aH NOEs between different
cysteines [28]. Our analysis showed that the disulfide parings (C4–
C19, C6–C14, C13–C36, C27–C33, C32–C57, and C45–C64) of
Rho and its P48A mutant followed the flavoridin-type but not
albolabrin-type pattern [18]. The secondary structures of the
P48A mutant consisted of three short regions of two-stranded
antiparallel b-sheets (residues 14–16 and 22–19, 32–34 and 37–39,
and 43–45 and 55–57). The formations of three two-stranded
antiparallel b-sheets were characterized by the CaH-CaH, CaH-
Figure 3. A structural comparison of Rho and its P48A mutant. (A) Superimpositions of the 3D structures of Rho (2PJF, cyan) and its P48A
mutant (2PJI, light purple). Structural alignments of (B) the nine-residue RGD loop containing RI[P/A]RGDMPD sequences of Rho and (C) its P48A
mutant. Ten of twenty Rho and its P48A mutant structures were aligned; the RMS deviations of the nine-residue backbone atoms of Rho and its P48A
mutant were 0.551 and 0.475 A ˚, respectively. The side chains of A48, R49, D51, and others are shown in purple, blue, red, and green, respectively.
doi:10.1371/journal.pone.0028833.g003
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slowly exchanging amide protons, and the downfield-shifted a
protons. Three short regions of antiparallel b-sheet structures have
been observed by the NOE pattern analysis (Figure S2).
The 3D Structure of the P48A mutant was calculated using
1048 experimentally derived restraints with an average of 15.4
restraints per residue (Table 3). The 20 best structures of the P48A
mutant from 100 initial structures are shown in Figure 1. The
backbone RMSD value of the P48A mutant is 1.0460.23 A ˚, and
the backbone RMSD values of the P48A mutant for three b-sheet
regions (13–14, 20–21, 33–34, 37–38, 43–45, and 55–57) was
0.3860.10 A ˚. Based on a Ramachandran analysis, all dihedral
angles of the P48A mutant were in the allowed region. A summary
of the restraints and structural statistics is presented in Table 3.
Overall, the tertiary structure of the P48A mutant has an
elongated and asymmetric shape and consists of three two-
stranded antiparallel b-sheets with many tight turns and loops.
No Structural Difference between Rho and its P48A
Mutant
The superimposition of the
15N-HSQC spectra of Rho and its
P48A mutant is shown in Figure 2. The chemical difference was
calculated using the formula: Dd~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:2DdN ðÞ
2z DdH ðÞ
2
q
. Chem-
ical shift differences larger than 0.3 ppm were observed only for
the residues close to mutation sites for R46, I47, R49, G50, D51,
and D55, which were 0.52, 0.42, 0.57, 0.49, 0.91, and 0.38 ppm.
Although there were chemical shifts of these residues, the amide
strips from I47 to M52 of
15N-edited NOESY of Rho and its P48A
mutant exhibited similar NOE patterns (Figure S3). Superimpos-
ing 3D structures of Rho and its P48A mutant showed that there
was no difference in their overall structures (Figure 3A). Their
RGDM motif, the binding sites for integrin, had a similar
conformation: a type-I turn. Ten out of twenty of Rho and its
P48A mutant structures were selected to align the nine-residue
RGD loop, and the RMS deviations of the nine-residue backbone
atoms of Rho and its P48A mutant were 0.55 and 0.40 A ˚,
respectively (Figures 3B and 3C). This structural analysis showed
that their RGD loops have the same backbone conformation.
No structural differences between the integrin a5b1
complexes of Rho and the P48A mutant
The dockings of Rho and the P48A mutant into integrin a5b1
were used to identify their integrin-interacting residues. The
models of the integrin a5b1 complexes were built using
HADDOCK 2.1 software [35]. The distance and hydrogen bond
restraints were derived from the X-ray structure of integrin avb3
complexed with a cyclic RGD pentapeptide (PDB code 1L5G),
and eight key interactions were found between integrin avb3 and
the R and D residues [37]. According to sequence and structure
alignments between integrins avb3 and a5b1, we identified the
corresponding residues of integrin a5b1. For example, the R
residue of the cyclic peptide forms a bidentate salt-bridge
hydrogen bond with the D218 residue av subunit, and its
corresponding responding residue of the a5 subunit was the
D227 residue. The carboxylate oxygen of the D residue of the
cyclic peptide forms hydrogen bonds with the residues S121 and
S123 of the b3 subunit, and the corresponding residues of the b1
subunit were residues S121 and S123. The other carboxyl oxygen
of the D residue of the cyclic peptide forms hydrogen bonds with
the residues Y122 and N215 of b3 subunit, and their
corresponding residues of integrin b1 were Y122 and N213
(Figure 4). Using these restraints, we docked Rho and the P48A
mutant to integrin a5b1, which, the analysis showed, resulted in
the same number of contacts (Table S2). The key contacts—seven
hydrogen bonds and two salt bridges between the R and D
residues of the RGD motif and integrin a5b1—were the same.
Figure 4. Docking models of Rho and its P48A mutant with integrin a5b1. Representation of Rho (cyan) and its P48A mutant (green) docked
on the surface of modelling a5b1. The propeller domain of the a5 subunit and the bA domain of the b1 subunit are in purple and yellow, respectively.
A snapshot of the interaction site is also shown. Side chains of the RGD motif of Rho and its P48A mutant are shown and labelled. Manganese ions at
MIDAS are in white.
doi:10.1371/journal.pone.0028833.g004
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residues and integrin a5b1 were 41 and 49, respectively. In
contrast, the P48 residue of Rho and the A48 residue of P48A
mutant did not interact with integrin a5b1. This is consistent with
our reported structures that both the A and P residues were
located in the interior of the RGD loop (Figure 3C).
Dynamics Differences between Rho and its P48A Mutant
1H-
15N correlated NMR spectroscopy was used to measure
15N
R1,
15N R2, and
1H-
15N NOE parameters for Rho and its P48A
mutant. They were measured at 600 MHz and 700 MHz
1Ht o
confirm the results. The NOE and R1 relaxation parameters of
Rho and its P48A mutant were similar throughout the sequence
(Figure 5 and Figure S4). The major differences between Rho and
the P48A mutant were found in the R2 relaxation parameters of
the R49 and D51 residues. Their R2 values, measured at
600 MHz
1H, were 8.3260.13 s
21 and 10.0260.10 s
21 for Rho
and 5.9860.10 s
21 and 6.5060.02 s
21 for the P48A mutant.
They were consistent with the results measured at 700 MHz
1H,
and the R2 values for the Rho residues R49 and D51 were 39%
and 54% higher than those of the P48A mutant (Table S3). The
square of the generalized order parameter, S
2, the effective
internal correlation time, te, and a conformational exchange
broadening parameter, Rex, for each backbone amide NH vector
were determined using model-free formalism to compare their
differences [34]. The optimized tm values of the P48A mutant was
determined to be 6.38 ns, and its obtained diffusion tensor was
fully asymmetric with D///D)=1.25. They were very similar to
the reported values of Rho and the measurement at 700 MHz
1H
[27].
The optimized values of S
2, te, and Rex of Rho and its P48A
mutant were obtained from the measurements of 600 and
700 MHz
1H (Figure 6, Figure S5, Table 4, and Table S3). The
observable S
2 differences between Rho and its P48A mutant were
found only in the RGD residues: the S
2 values of the R49, G50,
and D51 residues of the P48A mutant were 29%, 14%, and 28%
lower than those of Rho. Their differences in RGD motif can be
seen more clearly in the plots shown in Figures 7A and 7B.
Furthermore, the major differences were found in te and in the
Rex of R49 and D51: the Rex values of R49 and D51 residues of
Rho were 0.91 s
21 and 1.42 s
21, but we found no Rex values for
the P48A mutant residues. The te values of R49 and D51 of Rho
were 0.11 ns and 0.19 ns, and those of the P48A mutant were
1.04 ns and 0.98 (Table 4). The te values of R49 and D51 residues
of Rho were 9.5 and 5.1 times higher than those of the P48A
mutant. The te difference in the RGD motif between Rho and the
P48A mutant can be seen clearly in the structural plot shown in
Figures 7C and 7D. These results suggest that the flexibility and
Figure 5. (A) A comparison of the relaxation parameters of Rho (&) and its P48A mutant (%).
15N-R1 with error. (B)
15N-R2 with error. (C)
1H-
15N
steady-state NOE with error. These experiments were done using 600-MHz NMR. Gaps indicate the proline residues. The b-sheet secondary structure
is shown in the top panel.
doi:10.1371/journal.pone.0028833.g005
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may be important for binding integrin a5b1. It has been shown
that the RGD loop and the C-terminal region of echistatin exhibit
concerted motions [17]. In contrast, these regions of Rho did not
exhibit concerted motions because no long-range NOEs between
their backbone atoms were identified (Figure S2).
Effect of N-terminal Residue Adjacent to the RGD Motif
on the Inhibition of Integrin a5b1
To study the effect of the N-terminal residue of the RGD motif
on the inhibition of integrin a5b1, we produced P48G, P48Y,
P48F, P48W, P48L, and P48I mutants in P. pastoris. Compared
with the P48A mutant, their inhibition of integrin a5b1 was 1.6,
5.3, 4.8, 3.3, 4.8, and 4.8 times lower (Table 5). The P48A and
P48G mutants exhibited highest inhibitory activity. In contrast,
the N-terminal residue containing the large hydrophobic amino
acids was less inhibitory. These results suggest that proteins
containing N-terminal alanine and glycine residues adjacent to the
RGD motif may increase their binding to integrin a5b1.
Discussion
The residues flanking the RGD motif of RGD-containing
proteins affect their binding specificities and affinities on integrins
[7,10,22,23,24,25,40]. In the present study, we showed that the
replacement of N-terminal proline with alanine or glycine adjacent
to the RGD motif in Rho increased their binding affinity to
integrin a5b1; similar results were found with Rho P48A mutants
having different C-terminal residues adjacent to the RGD motif.
No structural differences between Rho and its P48A mutant or
between their integrin a5b1 complexes were found. The only
difference was found in the backbone dynamics of the RGD
residues. The proline-to-alanine mutation increased the flexibility
of the RGD residues and the fast motion of the R and D residues
on the ps-ns timescale. These results showed that the N-terminal
proline residue adjacent to the RGD motif of Rho affects its
function and dynamics, but does not affect the conformation of the
RGD motif, which suggests that the flexibility and the motions of
the RGD residues may be important for their interaction with
integrin a5b1.
Proline residue is the only common imino acid in proteins with
a bulky pyrrolidine ring that restricts the conformational range of
its adjacent residues. The lack of a proton on the imino nitrogen
of proline blocks the hydrogen-bond formation required for a-
helix and b-sheet secondary structures, and thus disrupts the
propagation of neighbouring secondary structures. Therefore, it
is commonly found in the turn and loop structures of proteins
[41,42]. The occurrence of a proline residue in a protein
sequence often has a strong influence on the protein’s stability,
structure, and function [42,43,44,45]. The effects of proline
residue are diverse, and they depend on their neighbouring
residues and structural contexts [42,43,44,45]. For example, the
replacement of proline on lysozyme and lambda repressor
caused protein instability [42,44]. In contrast, the replacement of
Figure 6. A comparison of the model-free parameters of Rho (&) and its P48A mutant (%). (A) The square of the generalized order
parameter S
2. (B) The effective internal correlation time te. (C) The conformational exchange broadening parameter Rex. Gaps indicate the proline
residues. The b-sheet secondary structure is shown in the top panel.
doi:10.1371/journal.pone.0028833.g006
Dynamic Differences between Rho & Its P48A Mutant
PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e28833proline on the a-subunit of tryptophan synthase and staphylo-
coccal nuclease increased their protein stability [46,47,48]. In
some cases, the effect of proline replacement on protein stability
can be only marginal [49,50]. The proline residue is also
important in many structural elements, such as an N-terminal
cap residue in the a-helix, a terminal residue in the a-helix, and
a corner residue in the b-turn structure. Our findings are an
example of a role for N-terminal amino acid adjacent to the
RGD motif in determining the activity of RGD proteins. We
found that the mutation of proline to alanine or glycine on Rho
increased their binding affinity to integrin a5b1. The N-terminal
proline residue adjacent to the RGD motif may provide an
unfavourable environment for inhibiting integrin a5b1. The
analyses of the primary sequences of disintegrins showed that
.98% of their RGD loops have an ARGD amino acid sequence
[26]. The RGD loop sequences of natural integrin a5b1 ligands,
such as fibronectin, osteopontin, and thrombospondins, are
GRGDS, GRGDS, and GRGD(A/I) [1]. These results suggest
Table 4. Relaxation data and dynamic parameters of RGD-containing proteins.
R1 (s
21)R 2 (s
21) NOE S
2 te (ns) Rex (s
21)
A48
P48Aa 1.6860.07 7.6560.13 0.6460.01 0.7460.02 1.0460.14
R49
WTb 1.6960.08 8.3260.13 0.4860.01 0.7560.01 0.1160.01 0.9160.26
R49
P48Aa 1.6360.04 5.9860.01 0.4260.01 0.5360.02 1.0460.06
R78
FN10c 0.46 3.25
G50
WTb 1.5560.02 5.0960.03 0.3260.02 0.5060.03 0.8460.08
G50
P48Aa 1.5160.02 4.9060.01 0.2860.01 0.4360.02 0.9360.06
G79
FN10c 0.39 2.75
D51
WTb 1.7260.03 10.0360.02 0.5060.02 0.8560.01 0.1960.03 1.4260.37
D51
P48Aa 1.6860.02 6.5060.02 0.4760.02 0.6160.02 0.9860.09
D80
FN10c 0.52 2.40
aRhodostomin P48A mutant from this study.
bRhodostomin from Chen et al. [27].
cDynamic properties of fibronectin type III domain reported by Carr et al. [52].
doi:10.1371/journal.pone.0028833.t004
Figure 7. Representations of the dynamic properties of Rho and its P48A mutant. A sausage representation of the backbone dynamics of
(A) Rho and (B) its P48A mutant. The diameter of the sausage is inversely proportional to the generalized order parameter of the corresponding
residue. The side chains of P48/A48, R49, and D51 are shown. The magnitudes of the generalized order parameter are blue, white, and red. A
representation of the effective internal correlation times of (C) Rho and (D) its P48A mutant. The residues containing the effective internal correlation
times (te).500 ps, .50 ps, and ,50 ps are shown in dark pink, light pink, and black. The residues without relaxation data and the fitting model are
shown in white.
doi:10.1371/journal.pone.0028833.g007
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not PRGD sequences for binding.
The synergy between structure and dynamics is essential to the
function of biological complexes. We found that the effect of the
N-terminal proline residue of the RGD motif in Rho on reducing
its binding affinity to integrin a5b1 may be due to its effect on the
dynamic properties of the RGD motif. The proline effect is
commonly attributed to the limitation of its backbone entropy.
The cis-trans isomerisation of the proline peptide bond is also
responsible for the activities of many proteins and peptides [51].
Proline isomerization can induce conformational heterogeneity
and control the binding and function of globular proteins. In the
present study, we found that the proline residue of P48A mutants
did not exhibit cis-trans isomerisation and had only a trans
conformation. The P48A mutation caused a decrease in the R2
values of the R and D residues, which resulted in a decrease of
the rigidity, the disappearance of conformational exchange, and
the increase of fast motion on the ps-ns timescale of the RGD
motif. The RGD motif, the integrin-binding site, of P48A mutant
is clearly more flexible on the ps-ns timescale than on that of
Rho, as indicated by both the dramatically lower-order
parameters and much larger effective internal correlation times.
This effect may facilitate the P48A mutants to interact with
integrin a5b1. This is consistent with the dynamic features of the
RGD motif in fibronectin, which preferentially binds to integrin
a5b1 [52]. The conformational freedom of the RGD loop in
P48A mutant results in high flexibility and solvent exposure of
this loop, which may be responsible for its fast recognition and
fitting to integrin a5b1 [17,34,53,54]. However, a detailed
investigation of the individual integrin a5b1 ligands may be
required.
In conclusion, we found that the N-terminal proline residue
adjacent to the RGD motif affects the function and dynamic
properties of the RGD motif, which shows that the dynamic
properties of the RGD motif in RGD-containing proteins may be
important for integrin recognition. Our functional analysis also
showed that the integrin a5b1 ligands prefer to have N-terminal
residue that contains either glycine or alanine amino acid. These
results provide important dynamic information for designing
potent RGD mimetics and serve as the basis for exploring the
structure and the functional relationships of RGD-binding
integrins and their ligands.
Supporting Information
Figure S1 Mass spectra of recombinant Rho variants.
(TIF)
Figure S2 Map of the NOE connectivities of detected in
Rho (A) and its P48A mutant (B). NOEs involving the
sidechain resonances are plotted below the diagonal, and those
involving only mainchain resonances are plotted above the
diagonal.
(TIF)
Figure S3 Amide strips from I47 to M52 of Rho (A) and
its P48A mutant (B) at pH 6.0. The dNN (i, i +1) and daN (i, i
+1) NOE connectivities are shown.
(TIF)
Figure S4 Comparison of the relaxation parameters of
Rho (&) and its P48A mutant (%).
15N R1 with error (A).
15N
R2 with error (B).
1H-
15N steady-state NOE with error (C) These
experiments were acquired using 700 MHz NMR.
(TIF)
Figure S5 Comparison of model-free parameters of Rho
(&) and its P48A mutant (D). Generalized order parameters
S
2, te, and Rex (calculated from 700 MHz relaxation data). Gaps
indicate the proline residues, and the b-sheet secondary structure
is shown. Comparison of internal timescale parameters, te, of Rho
and its P48A Mutant (B). Only some fitting models resulted in a te
term. Comparison of the conformational exchange terms, Rex, for
Rho and its P48A mutant (C). Only some fitting models resulted in
an Rex term.
(TIF)
Table S1 Molecular weights of recombinant Rho vari-
ants.
(DOC)
Table S2 Summary of the interactions between protein
and integrin.
(DOC)
Table S3 Relaxation data and dynamic parameters of
Rho and P48A mutant (700 MHz).
(DOC)
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